APA Alıntı

Elfiky, A. A., & Elshemey, W. M. (2016). IDX-184 is a superior HCV direct-acting antiviral drug: A QSAR study. Med Chem Res.

Chicago Stili Alıntı

Elfiky, Abdo A., ve Wael M. Elshemey. "IDX-184 Is a Superior HCV Direct-acting Antiviral Drug: A QSAR Study." Med Chem Res 2016.

MLA Alıntı

Elfiky, Abdo A., ve Wael M. Elshemey. "IDX-184 Is a Superior HCV Direct-acting Antiviral Drug: A QSAR Study." Med Chem Res 2016.